Trial intelligence / Profile preview

Comparison of lacosamide versus topiramate for migraine control

IRCT20240930063218N1Phase 3Completed

Sponsor
Qom University of Medical Sciences
Start
Oct 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of lacosamide and topiramate in migraine (2 arms), sponsored by Qom University of Medical Sciences. Started Oct 2024; status: completed.

02

Drugs

lacosamidetopiramate
03

Conditions

migraine

Beyond the preview

Go deeper on IRCT20240930063218N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20240930063218N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call